Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

Clinical trial NCT07699770 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07699770
Sponsor: Tang-Du Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorders (NMOSD)Neuropathic Pain

Start date: 2026-06-15
Primary completion: 2027-10-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.